Oncopeptides — Major Shareholding Notification 2022

Jul 21, 2022

Issuer Oncopeptides AB

Holder

Redmile Group, LLC

Instrument

Instrument	Common shares SE0009414576
Before the transaction
Shares	0
Voting rights	0
Transaction
Reason for major shareholding notification Other
Date	19/07/2022
Limit for number of shares	5 %
Limit for number of votes	5 %
After the transaction
Quantity
Shares	7,323,651
Directly held voting rights	0
Indirectly held voting rights	7,323,651
Percentage
Directly held shares	8.10419 %
Directly held voting rights	0 %
Indirectly held voting rights	8.10419 %

Resulting distribution of total holdings

	Percentage of voting rights:	Number of underlying shares:
Shares	8.10419 %	7,323,651
Instruments - FITA Ch. 4, section 2, first paragraph, line 2
Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled
- Cash settled
Total	8.10419 %	7,323,651

Chain of controlling companies

	Voting rights % Voting rights Company
3,661,826 4.0521		Redmile Biopharma Investments III, L.P.
2,392,985 2.64803		Redmile Strategic Master Fund, LP
1,268,840 1.40407		Redmile Capital Offshore II Master Fund, Ltd (Strategic Sleeve)
Group total holdings
Voting rights		7,323,651
Percentage of voting rights 8.10419

Notes (other relevant informations according to law) Share issue

Published

21/07/2022 09:54

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25